Luis Inglada

1.9k total citations · 1 hit paper
17 papers, 907 citations indexed

About

Luis Inglada is a scholar working on Epidemiology, Hepatology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Luis Inglada has authored 17 papers receiving a total of 907 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Epidemiology, 5 papers in Hepatology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Luis Inglada's work include Pneumonia and Respiratory Infections (3 papers), Antibiotic Use and Resistance (3 papers) and Urinary Tract Infections Management (3 papers). Luis Inglada is often cited by papers focused on Pneumonia and Respiratory Infections (3 papers), Antibiotic Use and Resistance (3 papers) and Urinary Tract Infections Management (3 papers). Luis Inglada collaborates with scholars based in Spain, Costa Rica and United States. Luis Inglada's co-authors include Wladimiro Jiménez, Vicente Arroyo, Pere Ginès, Àngels Ginès, Àngels Escorsell, Joan Rodés, Joan Saló, Miquel Navasa, Joan Clària and Antoni Rimola and has published in prestigious journals such as Gastroenterology, PLoS ONE and Hepatology.

In The Last Decade

Luis Inglada

17 papers receiving 873 citations

Hit Papers

Incidence, predictive factors, and prognosis of the hepat... 1993 2026 2004 2015 1993 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Incidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis with ascites
    1993 625 citations Àngels Ginès, Àngels Escorsell et al. Gastroenterology profile →

Peers

Luis Inglada
I. Fouzas Greece
Andreas Umgelter Germany
Peter Schellongowski Austria
Deepak Joshi United Kingdom
Edna Strauss Brazil
A. Rimola Spain
Marek Pacholczyk Poland
Tiago Sevá‐Pereira Brazil
Ignatius K.P. Cheng China
Xavier Amiot France
I. Fouzas Greece
Luis Inglada
Citations per year, relative to Luis Inglada Luis Inglada (= 1×) peers I. Fouzas

Countries citing papers authored by Luis Inglada

Since Specialization
Citations

This map shows the geographic impact of Luis Inglada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luis Inglada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luis Inglada more than expected).

Fields of papers citing papers by Luis Inglada

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luis Inglada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luis Inglada. The network helps show where Luis Inglada may publish in the future.

Co-authorship network of co-authors of Luis Inglada

This figure shows the co-authorship network connecting the top 25 collaborators of Luis Inglada. A scholar is included among the top collaborators of Luis Inglada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luis Inglada. Luis Inglada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Álvarez, Yolanda, Sara Alonso, Luis Inglada, et al.. (2023). Innate IRE1α-XBP1 activation by viral single-stranded RNA and its influence on lung cytokine production during SARS-CoV-2 pneumonia. Genes and Immunity. 25(1). 43–54. 2 indexed citations
2.
Fuente, Javier de la, Díez García F, Capdevila Ja, et al.. (2019). Inadequate empirical antimicrobial treatment in older people with bacteremic urinary tract infection who reside in nursing homes: A multicenter prospective observational study. Geriatrics and gerontology international. 19(11). 1112–1117. 6 indexed citations
3.
Artero, Arturo, Luis Inglada, Capdevila Ja, et al.. (2018). The clinical impact of bacteremia on outcomes in elderly patients with pyelonephritis or urinary sepsis: A prospective multicenter study. PLoS ONE. 13(1). e0191066–e0191066. 19 indexed citations
4.
Pérez‐Castrillón, José Luis, Daniel Antonio de Luis, Luis Inglada, et al.. (2012). Efecto de telmisartan sobre marcadores del remodelado óseo en pacientes hipertensos. Nutrición Hospitalaria. 27(1). 276–280. 2 indexed citations
5.
Pérez-Castrillón, José-Luis, Daniel Antonio de Luis, Luis Inglada, et al.. (2012). [Telmisartan effect's on remodelling bone markers in hypertensive patients].. PubMed. 27(1). 276–80. 5 indexed citations
6.
Armentia, Alicia, Fernando Pineda, Ricardo Palácios, et al.. (2011). Food anaphylaxis in antiphospholipid syndrome and thrombosis. Allergologia et Immunopathologia. 39(4). 212–221. 1 indexed citations
7.
Martínez, María Ángeles, et al.. (2006). Assessment of antibiotic prescription in acute urinary tract infections in adults. Journal of Infection. 54(3). 235–244. 29 indexed citations
8.
Olmo, Juan Carlos Martín del, Miguel Toledano, José Ignacio Jiménez Blanco, et al.. (2003). ERCP's role in the management of acute biliary-pancreatic pathology in the laparoscopic era.. PubMed. 6(4). 353–7. 2 indexed citations
9.
Inglada, Luis, et al.. (2001). Appropriateness of antibiotic prescriptions in community-acquired acute pediatric respiratory infections in Spanish emergency rooms. The Pediatric Infectious Disease Journal. 20(8). 751–758. 39 indexed citations
10.
Bouza, José Marı́a Eiros, et al.. (2000). Assessment of Antibiotic Prescription in Acute Respiratory Infections in Adults. Journal of Infection. 41(1). 73–83. 58 indexed citations
11.
Lázaro, A., et al.. (1999). [Practice variation and appropriateness study of antimicrobial therapy for acute pharyngotonsillitis in adults].. PubMed. 17(6). 292–9. 7 indexed citations
12.
Orduña, Antonio, et al.. (1997). Relation of hepatitis C virus genotypes to risk factors and hepatic disease in Spanish patients. Clinical Microbiology and Infection. 3(6). 647–652. 4 indexed citations
13.
Castro, Ángeles, Luis Inglada, M. Diago, et al.. (1997). Multicenter Randomized, Controlled Study of Intramuscular Administration of Interferon-β for the Treatment of Chronic Hepatitis C. Journal of Interferon & Cytokine Research. 17(1). 27–30. 12 indexed citations
14.
Ginès, Àngels, Àngels Escorsell, Pere Ginès, et al.. (1993). Incidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis with ascites. Gastroenterology. 105(1). 229–236. 625 indexed citations breakdown →
15.
Cabrera, Juan J., Luis Inglada, Enrique Quintero, et al.. (1991). Large-volume paracentesis and intravenous saline: Effects on the renin-angiotensin system. Hepatology. 14(6). 1025–1028. 32 indexed citations
16.
Quiroga, Juan Antonio, Inmaculada Castillo, Juan Carlos Porres, et al.. (1990). Recombinant γ-interferon as adjuvant to hepatitis B vaccine in hemodialysis patients†. Hepatology. 12(4). 661–663. 63 indexed citations
17.
Ordï, Jaume, et al.. (1988). [Renal cell carcinoma with appearance of a multilocular cystic mass: rarity and diagnostic difficulty of the case].. PubMed. 12(3). 282–7. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by I. Fouzas Breakdown of academic impact, for papers by Andreas Umgelter Breakdown of academic impact, for papers by Peter Schellongowski Breakdown of academic impact, for papers by Deepak Joshi Breakdown of academic impact, for papers by Edna Strauss Breakdown of academic impact, for papers by A. Rimola Breakdown of academic impact, for papers by Marek Pacholczyk Breakdown of academic impact, for papers by Tiago Sevá‐Pereira Breakdown of academic impact, for papers by Ignatius K.P. Cheng Breakdown of academic impact, for papers by Xavier Amiot
Rankless by CCL
2026